1,038
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors

, , , &
Pages 730-736 | Received 06 May 2014, Accepted 01 Sep 2014, Published online: 27 Aug 2015

References

  • Stockert AL, Shinde SS, Anderson RF, Hille R. The reaction mechanism of xanthine oxidase: evidence for two-electron chemistry rather than sequential one-electron steps. J Am Chem Soc 2002;124:14554–5
  • Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 2002;9:195–217
  • Hille R. Structure and function of xanthine oxidoreductase. Eur J Inorg Chem 2006;10:1913–26
  • Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87–114
  • Biagi G, Giorgi I, Pacchini F, et al. 2-Alkyloxyalkylthiohypoxanthines as new potent inhibitors of xanthine oxidase. Farmaco 2001;56:809–13
  • Brien DE, Springer RH, Albert TNA, et al. Purine analog inhibitors of xanthine oxidase – structure–activity relationships and proposed binding of the molybdenum cofactor. J Heterocycl Chem 1985;22:601–34
  • Oettl K, Reibneggar G. Pteridines as inhibitors of xanthine oxidase: structural requirements. Biochim Biophys Acta 1999;1430:387–95
  • Nepali K, Singh G, Turan A, et al. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. Bioorg Med Chem 2011;19:1950–8
  • Nepali K, Agarwal A, Sapra S, et al. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors. Bioorg Med Chem 2011;19:5569–76
  • Dhiman R, Sharma S, Singh G, et al. Design and synthesis of aza-flavones as a new class of xanthine oxidase inhibitors. Arch Pharm Chem Life Sci 2012;346:7–16
  • Sharma S, Sharma K, Ojha R, et al. Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors. Bioorg Med Chem Lett 2014;24:495–500
  • Shukla S, Kumar D, Ojha R, et al. 4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors. Arch Pharm Chem Life Sci 2014;347:1–10
  • Shi Y, Zhou C. Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents. Bioorg Med Chem Lett 2011;21:956–60
  • Hur SY, Kim TE, Park YG, et al. Natural compounds, fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Exp Mol Med 2005;37:436–46
  • Devji T, Reddy C, Woo C, et al. Pancreatic anticancer activity of a novel geranylgeranylated coumarin derivative. Bioorg Med Chem Lett 2011;21:5770–3
  • Reddy NS, Mallireddigari MR, Cosenza S, et al. Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity. Bioorg Med Chem Lett 2004;14:4093–7
  • Xue H, Lu X, Zheng P, et al. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide a with druggable profile. J Med Chem 2010;53:1397–401
  • Manvar A, Bavishi A, Radadiya A, et al. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains. Bioorg Med Chem Lett 2011;21:4728–31
  • Yeh J-Y, Coumar MS, Horng J-T, et al. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. J Med Chem 2010;53:1519–33
  • Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease. Bioorg Med Chem 2012;20:1175–80
  • Piazzi L, Cavalli A, Colizzi F, et al. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. Bioorg Med Chem Lett 2008;18:423–6
  • Lin CM, Huang S-T, Lee F-W, et al. 6-Acyl-4-aryl/alkyl-5,7-dihydroxycoumarins as anti-inflammatory agents. Bioorg Med Chem 2006;14:4402–9
  • Curini M, Epifano F, Maltese F, et al. Synthesis of collinin, an antiviral coumarin. Aust J Chem 2003;56:59–60
  • Chang WS, Chiang HC. Structure-activity relationship of coumarins in xanthine oxidase inhibition. Anticancer Res 1995;15:1969–73
  • Lin HC, Tsai SH, Chen CS, et al. Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem Pharmacol 2008;75:1416–25
  • Umamaheswari M, Madeswaran A, Asokkumar K, et al. Discovery of potential xanthine oxidase inhibitors using in silico docking studies. Der Pharm Chem 2011;3:240–7
  • Dhar DN. The chemistry of chalcones and related compounds. New York (NY): John Wiley & Sons; 1981:5–9
  • Star AE, Marby TJ. Flavonoid frond exudates from two Jamaican ferns. Pityrogramma tartarea and P. calomelanos. Phytochemistry 1971;10:2817–18
  • Cos P, Ying L, Calomme M, et al. Structure–activity relationship and classification of flavonoids as inhibitors of xanthine-oxidase and superoxide scavengers. J Nat Prod 1998;61:71–6
  • Da-Silva SL, Da-Silva A, Honorio KM, et al. The influence of electronic, steric and hydrophobic properties of flavonoid compounds in the inhibition of the xanthine oxidase. J Mol Struct Theochem 2004;684:1–8
  • Lin CM, Chen CS, Chen CT, et al. Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun 2002;294:167–9
  • Niu Y, Zhu H, Liu J, et al. 3,5,2′,4′-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor. Chem Biol Interact 2011;189:161–6
  • Nepali K, Sharma S, Sharma M, et al. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur J Med Chem 2014;77:422–87
  • Moreau J, Hubert C, Batany J, et al. Metal-free bronted acid catalyzed formal [3+3] annulation. Straight synthesis of dihydro-2H-chromenones, pyranones, and tetrahydroquinolinones. J Org Chem 2009;74:8963–73
  • Jacquot Y, Refouvelet B, Bermont L, et al. Synthesis and cytotoxic activity of new 2,4-diaryl-4H,5H-pyrano[3,2-c]benzopyran-5-ones on MCF-7 cells. Pharmazie 2002;57:233–7
  • Liu Y, Zhu J, Qian J, et al. Gold(III)-catalyzed tandem conjugate addition/annulation of 4-hydroxycoumarins with α,β-unsaturated ketones. J Org Chem 2011;76:9096–101
  • Bagdi AK, Majee A, Hajra A. Regioselective synthesis of pyrano[3,2-c]coumarins via Cu(II)-catalyzed tandem reaction. Tetrahedron Lett 2013;54:3892–5
  • Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 2002;9:195–217
  • Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inihbitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87–114
  • Guru Nanak Dev University. New class of non purine xanthine oxidase inhibitors. Calculated from http://www.molinspiration.com/cgi-bin/properties [last accessed 1 Jun 2014]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.